Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Medcon Rehab IV > Diabetes > Flashcards

Diabetes Flashcards

1
Q

Types of DM

Type I (Juvenile onset)

A
  • MAY be autoimmune→ Body produces antibodies that attack beta cells
  • Initially→ ability of beta cells to produce insulin is impaired
  • Later→ Pancreas stops producing the hormone insulin
    • Usually young, but can be 20’s or >
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Types of DM

Type II

A
  • Initially→ Insulin present BUT insulin resistance exists: cells do not recognize insulin
  • Later→ Pancreas stops producing insulin
  • Usually adulthood, BUT growing #’s of children w/ TIIDM
    • Young as 3
  • NOTE: TIIDM is REVERSIBLE!!!!!!!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Symptoms of Diabetes

A
  • HypERglycemia, metabolic acidosis (kidneys), polydipsia/polyuria, dehydration, wt loss, INC food intake, blurred vision, Incd yeast infxs (infx’s love sugar), skin infx’s
  • Long-term issues:
    • retinopathy, nephropathy, neuropathy, autonomic neuropathy, cataracts, glaucoma, CHD, peripheral vascular disease (PVD), stroke*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Criteria for Dx of Diabetes and Prediabetes

Looking @ Oral Glucose Tolerance Test (OGTT), Fasting Plasma Glucose Test (FPG) → see chart

also note A1C %

A
  • Prediabetes
    • FBG→ >/= 100 but <126
    • OGTT→ >/= 140 but <200
    • A1C%→ 5.7-6.4%
  • Diabetes
    • FBG→ >/= 126 (no cals for 8hrs)
    • Hyperglycemia w/ plasma glucose >/= 200
    • 2hr plasma glucose >/= 200 during OGTT
    • A1C%→ >/= 6.5%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Correlation of A1C w/ Plasma Glucose Lvl

A
  • A1C %→ 6 (upper lvl of normal) Plasma Glu (mg/dL)→ 126 (DM)
  • A1C %→ 7 Plasma Glu (mg/dL)→ 154

see chart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are normal glucose levels?

Depends on timing of the last meal or snack***

A
  • Fasting NORMAL→ 70-100 mg/dL
  • BELOW 70→ HypOglycemia
  • ABOVE 100→ pre-diabetes
  • ABOVE 126→ diabetes and hypERglycemia*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Normal Glucose Lvls

Preprandial (fasting or before meals) vs Post-prandial (after meal)

A
  • Preprandial→ 70-100 mg/dL for overnight and before meals
  • Post-prandial→ <140 mg/dL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Glycemic Goals NON-Pregnant Adults

A
  • Reasonable A1C goal for nonpreg→ <7% (53 mmol/mol)
  • More stringent goals (<6.5%)→ IF achievable w/out sig. hypos or other adverse effects
  • LESS stringent goals (<8%)→ pts w/ hx of severe hypOglycemia, limtd life expect, or other cond’s that make <7% diff to attain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Glucose Monitoring

Self-monitoring

A

Reqs single drop of blood which can be w/drawn by lancet or by meter itself from fingertip or forearm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Glucose Monitoring

CHECK FREQUENTLY! (6-10x daily)

A

6-10x Daily

  • BEFORE meals, 2hrs postprandial, BEFORE bedtime, 2AM (1x/month), when suspect LOW blood glucose, after treating LOW blood glucose until normoglycemic
  • BEFORE exercise****→ exercise acts as insulin**
  • Prior to critical tasks→ e.g. driving
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Actions of Insulin

A
  • INC storage of glucose as glycogen
  • INC glucose utilization→ pulls glucose INTO cells
  • Stimulates carrier mediated transport of glucose INTO cells
  • Incs triglyceride storage in adipose tissue and INCs triglyceride synthesis in Liver
    • Lipogenic→ WHY its hard to lose weight on insulin**
  • INCs PRO synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Factors Regulating Insulin Release

Release stimulated by:

A
  • Glucose
  • Amino Acids, Fatty Acids
  • Parasympathetic NS
  • Incretins
    • Glucagon-like Peptide-1 (GLP-1)→ released into small intestine; Stims Beta cells in pancreas to release insulin*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Factors Regulating Insulin Release

Release inhibited by:

A
  • SNS→ glucose TO muscle; bc we need it most when SNS “fight or flight” is revved up!!!!
  • Somatostatin
  • Glucagon*
  • Epi*
  • Glucocorticoids
  • Growth Hormone (GH)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Effect on Hormones on Blood Glucose Lvls:

A
  • DEC Blood Glucose→ Insulin (Main regulatory hormone)
  • INC Blood Glucose→ Glucagon, Epi, Glucocorticosteroids, Growth Hormone (All Main counter-regulatory hormones)

see chart and notice main actions, main stimulus for secretion***

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Insulin Molecule

Know the *, look @ picture

A
  • *Produced in pancreatic Beta Cell
  • PROinsulin→ Has C-chain
  • When insulin released→ C-chain disassociates (not always in T2DM though)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Insulin production happens where???

A

Pancreas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Insulin production

Do NOT get hung up on this, read description, note picture

A
  • Glucose enters beta cell via Glut 2 transporter→ undergoes metabolism producing ATP→ ATP blocks OUTflow of K+ ions→ membrane DEpolarization→ Depolarization opens voltage-gated Ca++ channels→ Ca++ influx→ Ca++ triggers exocytosis + insulin RELEASE***
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Insulin Action

How does it get the Glucose INTO cell?

A

GLUT-4 vesicle

allows GLU mc to enter cell→ used for energy (ATP) OR stored (glycogen/triglycerides)

NOTE: Insulin Resistance is when cells NO LONGER RESPOND to this signal!!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Incretins

what are they?

A

Peptide hormones released from GI tract

  • Glucagon-like insulinotropic peptide (GIP)
  • Glucagon-like peptide-1 (GLP-1)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Incretins

Function

A
  • Released when food ingested, EARLY stimulus to insulin secretion*
  • INHIBIT pancreatic glucagon secretion
  • SLOW rate of absorption of digested food→ REDUCE gastric emptying
  • REDUCES appetite== wt loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Exogenous Insulin

2 types:

A
  1. Basal Insulin→ think overnight, bw meals
  2. Prandial (mealtime) Insulin→ think limits spike in blood sugar AFTER meals
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Exogenous Insulin:

Basal Insulin

A
  • Suppresses glucose production while fasting
    • Overnight, bw meals
  • Maintains nearly constant blood glu and day long insulin lvls
  • ~50% of daily insulin needs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Exogenous Insulin

Prandial (mealtime) insulin

A
  • LIMITS hypERglycemia after meals
  • IMMEDIATE rise and sharp peak ~1 hr after injection
  • 10-20% daily insulin req. @ ea meal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Types of Insulin

A
  • Ultra short acting
  • Regular
  • Intermediate
  • Peakless- LONG ACTING
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Glycemic Recommendations for Adults WITH DM

A
  • A1C→ <7%
  • Preprandial capillary plasma glu→ 80-130 mg/dL
  • Peak Postprandial cap. plasma glu→ <180 mg/dL
  • Postprandial @ 2hrs→ <160 mg/dL
  • Fasting blood glu→ 80-110mg/dL
  • Bedtime→ 110-130 mg/dL
  • 3AM→ >80 and <120 mg/dL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What lvl of blood glucose is DEADLY?

A

<20 mg/dL

27
Q

Adverse Effects of Insulin

HypOglycemia

WHEN can this occur?

A
  • If insulin too high, missed meal, *strenuous exercise (remember exercise acts as insulin!!!!)
28
Q

Adverse Effects of Insulin

HypOglycemia

S/S

A
  • HA, fatigue, hunger, TACHYcardia, sweating, anxiety, confusion, weakness, faintness, coma (<20mg/dL)
29
Q

Another Adverse Effect of Insulin

Rebound hypERglycemia

A
  • Rebound HIGH blood glu lvl in response to LOW blood glu
  • Ex. high blood sugar in morning due to excess amt of insulin during night
30
Q

Adverse effects of insulin

Wt. Gain

A

Remember insulin is Lipogenic

  • Insulin→ INC triglyceride storage in adipose tissue and INCs triglyceride synthesis in liver→ Lipogenic
    • hard to lose wt on insulin*
31
Q

HypOglycemia Risk Factors

A

Inc’ing age, delayed or reduced food intake, Long standing disease, recent hypoglycemic episode, Infx (sugar loves infx’s), alcohol intake

32
Q

HypOglycemia Protocol

2 Rules:

A
  1. If pt on pump→ IMMEDIATELY discontinue insulin infusion
  2. Rule of 15****
33
Q

HypOglycemia Protocol

Rule of 15

When does this kick in/when start it?

A

If blood glucose is 70mg/dL or BELOW******

34
Q

If blood glucose is 70mg/dL or BELOW******

WHAT RULE?

A

RULE OF 15

35
Q

HypOglycemia Protocol

Rule of 15

A

If blood glucose is 70mg/dL or BELOW:

  • Eat 15g carbs→ Recheck glucose lvl in 15mins→ If not ABOVE 70, eat another 15g carbs→ Test again in 15mins→ if not ABOVE 70, eat another 15g carbs and call MD
  • NOTE: 15g CHO= 4oz juice or soda (NOT DIET!!!!!), 1 Tbl of table sugar or honey***
36
Q

Comparison bw HypOglycemia vs HypERglycemia

Chart first

A

See chart

NOTE: Both have COMA in common….

37
Q

HypOglycemia vs HypERglycemia

HypO→

A
  • Nervous, shaky
  • Hungry
  • HA
  • Confused
  • Cold clammy skin
  • TACHYcardia
  • Irritability
  • Coma
38
Q

HypOglycemia vs HypERglycemia

HypER→

Note that these all make sense bc now blood is flooded w/ sugar…..TOO MUCH SUGAR CIRCULATING IN BLOODSTREAM!!!!

A
  • Weak, tired
  • Freq. urination*
  • INCd thirst*
  • DECd appetite
  • Blurry vision
  • Fruity breath*
  • Itchy dry skin
  • SZ’s
  • Coma
39
Q

Modes of Insulin Administration

Subcutaneous Injections

A
  • Site must be rotated
  • Lower abdomen, upper outer arms, upper outer thighs, buttocks
  • Rate of injection FASTER into abdomen vs arm or leg***
40
Q

Modes of Insulin Administration

Subcutaneous Injection

Guidance in Therapy aka we do NOT want to INC the rate of absorption when they are in therapy so there are precautions we can take to ensure this does not happen and they become hypOglycemic!!!

A
  • ***DO NOT USE:
    • hot packs, water therapy, infrared, US near inj site, or Exercise→ ALL accelerate absorption
    • Also NO massage in area
    • HEAT INCs absorption== BAD!
  • NOTE: Rise in ambient temp also causes INC in insulin absorption as much as 50% w/ INC of 15*C. Cold does OPPOSITE
41
Q

Modes of Administration

A
  • Portable pen injectors
  • Jet injectors
  • Dry powder inhaled insulin
  • External pump
  • Implantable pump→ sx implanted on L. side of abdomen
42
Q

Insulin Pump + CGM (Continuous Glucose Monitoring)

A

see pics

43
Q

Mode of Admin

Other example

A

see pics

44
Q

Agents of Type II DM

Metformin

MOA, Indications, ADRs

A
  • MOA: Inhibits gene expression for gluconeogenesis (prod of glucose)
    • Reduces gluconeogenesis in liver
    • Stims glycolysis in peripheral tissue→ improves glucose utilization in SK MM
    • Reduce CHO absorption
    • INC fatty acid oxidation
    • Reduce circulating LDLs and VLDLs, and triglycerides
    • INC insulin binding to its receptor
    • Modest wt loss****
    • Does NOT cause hypOglycemia
  • Indications: drug of first choice→ UNLESS renal and hepatic issues
  • ADRs: mild→ nausea, diarrhea, rarely lactic acidosis

FUN FACT:** Recent data shows it helps **reduce rate of cx in pts w/ T2DM and may reduce mortality**

45
Q

Agents for Type II DM

Sulfonylureas

MOA, ADRs

A
  • MOA: Insulin secreatogues→ Blocks ATP sensitive K+ channels, facilitates insulin (by Ca+ flood) release, suppresses glucagon, BUT stimulates appetite/caues wt. gain
  • ADRs: HypOglycemia (esp elderly), mild wt gain, binds to albumen (if w/ other drug, warfarin→ drug-drug interaction)
46
Q

Agents for Type II DM

Thiazolidinediones (glitazones)

MOA, ADRs

A
  • MOA: Insulin sensitizers (gets cells to recognize insulin)
    • INC insulin sensitivity in mm, liver, adipose tissue→ improves insulin resistance
    • Improves lipid and cholesterol lvls
    • may delay progress. of dis.
  • ADRs: fluid retention, wt gain, incd risk fx’s, possible risk of bladder cx w/ Actos (ex. of drug)
47
Q

Agents for Type II DM

Incretin Mimetics

MOA, ADRs

A
  • MOA: glucagon-like peptide (GLP-1) analog
    • INCd secretion of insulin
    • Beta cells bathed in GLP, cell morphology was maintained and slowed cell death
    • Additional→ inhibits glucagon secretion, suppress appetite
  • ADRs: nausea, vom, diarrhea, risk of mild-mod hypOglycemia when used w/ sulfonylurea so reduce sulfonylurea dose
48
Q

Summary of Incretin Actions on Diff Target Tissues

A

NOTE: Cardiac protective*

49
Q

Agents for Type II DM

Pipeptidyl Peptidase-4 (DPP-4) Inhibitors

MOA, ADRs

A
  • MOA: competitively inhibit DPP-4 enzyme, slows incretin degradation-potentiating glucagon-like peptide-1 (GLP-1)
    • Reduces HgA1C by .7-.9%
  • ADRs: nasopharynigitis, nausea
50
Q

Agents for Type II DM

SGLT2 Inhibitors (NEWEST*)

MOA, ADRs

A
  • MOA: Sodium glucose cotransporter 2 (SGLT2) inhibitor preventing the resportion of glucose in kidney→ results in INCd urinary glucose excretion, and a lowering of blood glucose lvls
    • SOME wt loss*
  • ADR: UTI, yeast infx (bc urine full of sugar), incd LE amps?
51
Q

Drug Effects on Glycemic Control

Type II DM

Chart

A

see chart

52
Q

Drug Effects on Glycemic Control

Type II DM

Drug Class: Sulfonylureas/meglitinides

MOA?

A

INC insulin release

53
Q

Drug Effects on Glycemic Control

Type II DM

Drug Class: Metformin***

KNOW THIS ONE!!!!

MOA?

A

DEC gluconeogenesis/INC insulin sensitivity

54
Q

Drug Effects on Glycemic Control

Type II DM

Drug Class: Thiazolidinediones

MOA?

A

Insulin Sensitizers

55
Q

Drug Effects on Glycemic Control

Type II DM

Drug Class: Incretins: exenatide, DPP-4 Inhibitors

MOA?

A

Beta cell and Non-Beta cell effects: preserve Beta cell function and enhance insulin release

56
Q

Drug Effects on Glycemic Control

Type II DM

Insulin

A

Replacement bc body no longer producing (Beta cells (in pancreas) no longer producing)

57
Q

Inc insulin Release

A

Sulfonylureas/meglitinides

58
Q

Dec gluconeogenesis/INC insulin sensitivity

A

Metformin***

59
Q

Insulin Sensitizers

A

Thiazolidinediones (PPAR-Beta agonists)

60
Q

Prevent glucose reabsorption from Kidneys

A

SGLT2 Inhibitors

61
Q

B-Cell and NON-B cell effects: preserve beta cell function and enhance insulin release

A

Incretins: exenatide, DPP-4 inhibitors

62
Q

Replaces insulin body no longer producing

A

Insulin

63
Q

Drug Effects on Glycemic Control

Type II DM

Drug Class: SGLT2 Inhibitors

MOA?

A

Prevent glucose reabsorption from Kidneys

Medcon Rehab IV (18 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions